BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.38
+0.08 (0.86%)
At close: Aug 7, 2026, 4:00 PM EDT
9.42
+0.04 (0.43%)
After-hours: Aug 7, 2026, 7:51 PM EDT
BioCryst Pharmaceuticals (BCRX) Revenue by Type
| Date | Product | Collaborative and Other |
|---|---|---|
| Jun 30, 2026 | 625.85M | 314.77M |
| Mar 31, 2026 | 630.77M | 254.95M |
| Dec 31, 2025 | 623.15M | 251.69M |
| Sep 30, 2025 | 593.30M | 6.52M |
| Jun 30, 2025 | 551.63M | 5.88M |
| Mar 31, 2025 | 497.18M | 6.30M |
| Dec 31, 2024 | 442.67M | 8.04M |
| Sep 30, 2024 | 404.06M | 8.52M |
| Jun 30, 2024 | 373.29M | 8.95M |
| Mar 31, 2024 | 345.80M | 9.59M |
| Dec 31, 2023 | 324.70M | 6.72M |
| Sep 30, 2023 | 312.02M | 5.54M |
| Jun 30, 2023 | 301.95M | 4.70M |
| Mar 31, 2023 | 286.33M | 3.35M |
| Dec 31, 2022 | 267.71M | 3.12M |